Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.

返回 Agenda

Topic 1 Session 4: An Overview of the Risk Management Process & the PRAC. The main components of the RMP

Speaker(s)

An Overview of the Risk Management Process & the PRAC. The main components of the RMP

Julie Williams, PhD

MHRA, United Kingdom

Expert Assessor

Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

Topic 1 Session 4: An Overview of the Risk Management Process & the PRAC. The main components of the RMP

Speaker(s)

An Overview of the Risk Management Process & the PRAC. The main components of the RMP

获得信息并保持参与